Owing to this dual mechanism of action, GLP-1 RAs have become the cornerstone of management of type 2 diabetes mellitus (T2DM), particularly in people with inadequate glycaemic control despite standard therapies [2]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.